TEST

CEVEC Pharmaceuticals is a leading provider of high-performance cell technology for the manufacturing of advanced bio-therapeutics from R&D to manufacturing scale.

The company’s product portfolio comprises platform technologies for gene therapy viral vectors (AAV, Adeno, Lenti and others) and complex recombinant proteins. ELEVECTA® is specifically designed for AAV manufacturing, while CAP® addresses Adeno, Lenti and other viruses. CAP® Go is the platform of choice for complex recombinant proteins.

STABLE AAV PRODUCER CELL LINES

RCA-FREE ADENO VIRAL VECTORS

GLYCO-OPTIMIZED PROTEINS

ASGCT ANNUAL MEETING 2020

MAY 12 TO MAY 15
BOSTON, USA

NEWSLETTER

Subscribe for the CEVEC Newsletter according to our Privacy Policy to receive the latest CEVEC News,
including Press Releases, Conference Information and Webinar Invitations.

© CEVEC Pharmaceuticals GmbH 2020